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“Everything is alive, everything is interconnected.”
[–Cicero 106 BCE]
Complex and coevolved interdependence is commonly observed be-
tween organisms that occupy the same ecological niches. However, con-
sidering the ecosystem of the mammalian intestine as complex and
important is relatively novel, with the earliest microbiome studies oc-
curring in the last century (Rosebury et al., 1954). Since then, studies
have demonstrated a largely mutualistic relationship between the
host and its bacterialmicrobiota,which promotes intestinal vasculariza-
tion and epithelial cell function, supports nutrient absorption, and limits
pathogen invasion (Brestoff and Artis, 2013; Stappenbeck et al., 2002;
Hooper et al., 2012). Moreover, crosstalk between intestinal bacterial
communities and the host fundamentally inﬂuences immune homeo-
stasis, host-protective immunity and disease-associated inﬂammation
(Brestoff and Artis, 2013; Belkaid and Hand, 2014). However, our un-
derstanding of how the other biological entities (archaea, viruses,
fungi, and mammalian parasites) that colonize the intestine communi-
cate with one another and the host is incomplete. ‘Transkingdom’ inter-
actions between these entities and the host can inﬂuence intestinal
ecosystem dynamics and immune homeostasis (Pfeiffer and Virgin,
2016). Here, we introduce the term ‘multibiome’ to encompass the
biodiverse collection of microscopic (bacteria, archaea, fungi) and mac-
roscopic (multicellularworms) organisms, aswell as viruses (not repre-
sented in phylogenetic kingdoms) that colonize mammals (Fig. 1). In
this review, we will discuss how each group individually inﬂuences
the host immune system, how intestinal colonization or infection is im-
pacted by other members of the multibiome, and how crosstalk be-
tween members of the multibiome and the host inﬂuences local and
systemic immune homeostasis, health, and disease.2. The Multibiome: Importance of Individual Groups
Mammalian physiology has undergone evolutionary optimization in
collaboration with the bacterial microbiome, as illustrated by the
physiologic defects that have been described in germ-free (GF) animals,
including impaired intestinal function, immune and metabolic homeo-
stasis. Bacterial microbiome reconstitution can restore the majority ofFig. 1. The multibiome. Due to the shortcomings of the terms microbiome and trans-
kingdom, we propose the introduction of the term multibiome. This all-encompassing
term accounts for viruses (that are not part of any taxonomic kingdom) and for
macrobionts such as helminth parasites. Each multibiome member (when present, in
the case of helminths) and the mammalian host, together, contribute their genetic
information to the holistic metagenome.these defects (Brestoff and Artis, 2013; Belkaid and Hand, 2014; El
Aidy et al., 2012). However, the recent demonstration that persistent in-
testinal virus colonization can restore a subset of intestinal morphology
and immune defects of germ-free mice indicates that non-bacterial
members of the multibiome can also provide critical developmental
cues to the host (Kernbauer et al., 2014).
The mammalian immune system has evolved multiple immune
pathways characterized by T helper (Th) cell subsets and their associat-
ed cytokines that are tailored toward distinct types of pathogens. Intra-
cellular bacteria and viruses typically induce pro-inﬂammatory type 1
responses (classically activated macrophage, cytotoxic T cells and Th1
cells), multicellular helminths can induce wound healing type 2 re-
sponses (alternatively activated macrophage and Th2 cells) and/or
tolerogenic responses (regulatory T cells (Treg)), and certain extracellu-
lar bacteria andmost fungi elicit type 17 responses (Th17 cells) (Fig. 2).
In this section, wewill discuss how distinct members of themultibiome
can elicit these pathways to inﬂuence immunity and inﬂammation.
2.1. The Bacterial Microbiome
The intestinal bacterial microbiome is comprised of trillions of indi-
vidual bacteria from approximately 1000 different species (Brestoff and
Artis, 2013). Within this vast diversity, examples of speciﬁc microbes
and collections of bacterial consortium have been shown to elicit im-
mune polarization (Fig. 2) through direct interaction with host intesti-
nal epithelial or dendritic cells as well as indirect mechanisms that
rely on bacterial metabolism. Multiple chronic inﬂammatory disorders
(CIDs) including inﬂammatory bowel diseases (IBD) like Crohn's and ul-
cerative colitis and extra-intestinal autoimmune disorders (multiple
sclerosis and rheumatoid arthritis) have been shown to be associated
with intestinal dysbiosis, which suggests that the bacterial microbiome
may contribute to the development or progression of inﬂammatory dis-
eases (Belkaid and Hand, 2014). However, it is important to note that
the dialog between the bacterialmicrobiome and the host is highly con-
textual and commensal-induced responses can be inﬂuenced by genet-
ics and environmental factors including infection history, nutrient
availability, and age, which have been reviewed elsewhere (Nicholson
et al., 2012).
2.2. The Virome
The virome consists of all bacteriophage, mammalian viruses and
the endogenous retroviruses that have integrated into the host's ge-
nome (Pfeiffer and Virgin, 2016). Despite the enormity of the intestinal
virome (estimated ten-foldmore particles than bacterial microbes), un-
derstanding its impact on health and disease is in its infancy. However,
the intestinal virome is likely an important regulator of immune ho-
meostasis; colonizing GF mice with a single persistent viral strain was
sufﬁcient to correct a subset of immune defects, including Type 1-
associated interferon responses (Kernbauer et al., 2014) (Fig. 2).
Supporting the hypothesis that the virome and the mammalian im-
mune system engage in ongoing cross-talk, the intestinal virome is ex-
panded in the context of Human Immunodeﬁciency Virus (HIV) and
Simian Immunodeﬁciency Virus (SIV)-induced acquired immunodeﬁ-
ciency (Monaco et al., 2016; Handley et al., 2012) and is dysregulated
in IBD patients (Norman et al., 2015). Additionally, a number of viral in-
fections have been associated with autoimmunity (enterovirus with
Type 1 Diabetes and Epstein Barr virus with MS) (Richardson and
Horwitz, 2014; Casiraghi et al., 2012). Thus, our current understanding
indicates that in certain contexts the virome can contribute to the devel-
opment or progression of various CIDs.
Curating and characterizing the human virome is challenging due to
the absence of a conserved gene region (e.g. bacterial 16S) and incom-
plete viral genome libraries (Pfeiffer and Virgin, 2016). However, with
the advent of metagenomic shotgun sequencing it is anticipated that
wewill gain a new appreciation of the role of the virome inmaintaining
Fig. 2. The immune response associated with each constituent of the multibiome. Type 1 responses are initiated by detecting microbe-associated molecular patterns. Type 1 pro-
inﬂammatory cytokines and cells target intracellular microbes, including bacterial pathogens, opportunistic commensal bacterial infection and viruses. The innate type 1 and 3 IFN
pathways are critical components of the antiviral immune response. Type 1 responses are pro-inﬂammatory and can cause collateral damage to the host if the immune response is not
balanced and regulated. Type 2 immune responses are triggered by helminth infections. A type 2 responses coordinates worm expulsion and rapid wound healing; however, it can
lead to ﬁbrosis if the immune response is not balanced and regulated. Regulatory responses are promoted by certain bacterial species (some Clostridia species, B. fragilis), and many
helminth infections. Their broad immunosuppressive actions contribute to self-tolerance and commensal multibiome-tolerance. They are also initiated during the resolution phase of
type 1, 2, and 3-promoting infections. Type 17 responses are triggered by extracellular bacterial pathogens, fungi and some epithelial cell binding commensal bacterial species. Type
17-associated cytokines promote mucosal barrier function, but are also widely implicated in autoimmune and CIDs.
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virome interactions can contribute to disease.
2.3. The Mycobiome
The mycobiome (fungal constituent of the multibiome) is less di-
verse and abundant than the bacterial microbiome (Underhill and
Iliev, 2014). Recent shotgun sequencing approaches suggest that fungi
account for approximately 0.1% of the intestinal microbiome, although
this is likely an underestimate of their true representation (Underhill
and Iliev, 2014). Fungi activate the type 17 axis of the immune system
(Fig. 2) and can contribute to local (gastric ulcers, food allergy sensitiza-
tion and colitis) and systemic (allergic airway) diseases (Mason et al.,
2012; Wheeler et al., 2016; Yamaguchi et al., 2006). Recent advances
in the sequencing and phylogenetic assignment of the mycobiome
may reveal further impacts on mammalian health and immunity
(Underhill and Iliev, 2014).
2.4. The Macrobiome
Themacrobiome consists of intestinal multicellular parasitic worms,
most commonly referred to as helminths (from the Greek word for
worm) (Hotez et al., 2008). Unlike bacteria, fungi, and viruses, hel-
minths are only present in about one-third of the global population
(Maizels, 2016). Many helminths complete part of their life cycle inthe host's intestine by securing themselves into the intestinal epitheli-
um, during which they disrupt the intestinal ecosystem and damage
the epithelium (Allen and Maizels, 2011). In response, mammalian
hosts activate type 2 responses that promote rapid intestinal epithelial
cell turnover, mucus production and increased gut motility to encour-
age helminth expulsion (Allen and Maizels, 2011) (Fig. 2). This can be
paired with an expanded Treg population and production of wound
healing molecules to limit inﬂammation and promote intestinal repair.
The coevolution of helminths and the host type 2 and regulatory re-
sponses has resulted in an immune-mediated truce where worms are
tolerated and host tissue damage is minimized (Allen and Maizels,
2011). Although helminths are commonly thought of as parasites, the
‘Old Friends’ hypothesis suggests that lack of exposure to these organ-
isms could have detrimental effects (Rook, 2010). The impact of
helminth-induced immune modulation in the context of co-infection,
vaccination efﬁcacy, and CIDdevelopment is discussedmore thoroughly
in a later section.
2.5. Communication BetweenMultibiomeMembers and the Host Regulates
Immune Homeostasis
Collectively, these ﬁndings indicate that constituents of the
multibiome can individually inﬂuence the host immune system. In a di-
verse intestinal ecosystem composed of all members of themultibiome,
each corresponding arm of the immune system can receive basal
Fig. 3. Multibiome-mediated regulation of immune polarization and homeostasis.
This illustration simpliﬁes the many interactions and pathways involved in multibiome-
host cross-talk down to the core T helper (Th) cell subsets they promote. It also
demonstrates how each Th subset is able to regulate, inhibit, or promote the activation
or function of another subset. During a proper immune response, balancing these
subsets is crucial to avoid pathology and generate a good memory response. Immune
cross-regulation is mediated through a variety of mechanisms including cytokines,
chemokines, receptor interactions, and transcription factor expression. Certain members
of the multibiome promote the expansion of different subsets of Th cells, which in turn
inhibit, promote, and/or balance the other subsets. T-bet expressing Th1 (activated in
response to bacteria and viruses) and GATA3 expressing Th2 cells (helminth-induced),
antagonize each other. Some bacterial species and helminths promote Foxp3-expressing
Tregs, which in turn limit the activation of Th1, Th2 and Th17 cells.
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each other, and regulatory T cells can dampen Th1, Th2 and Th17-
mediated inﬂammation (Fig. 3). Thus, a rich and diverse multibiome
may promote immune homeostasis, while the absence of helminths or
a lowabundance of immunomodulatory bacteriamay alter the response
to other viral, bacterial and fungal stimuli. This imbalance may play a
role in the development or progression of various chronic inﬂammatory
or autoimmune diseases.
3. Multibiome Members Interact in a Dynamic Ecosystem
The intestinal lumen harbors a complex and interactive ecosystem,
where colonization or infection can be inﬂuenced by inter-multibiome
cross-talk or by host responses. In this section, we will focus on inter-
multibiome interactions that inﬂuence colonization across taxonomic
boundaries.
3.1. Interactions Between Members of the Multibiome
Similar to other ecosystems, the intestinal community is dynamic,
responsive, and regulated by interactions between distinct biological
entities. For example, bacteriophage can shape the bacterial
microbiome by lysing commensal or pathogenic bacteria and driving
bacterial evolution (Duerkop and Hooper, 2013). The bacterial
microbiome can inhibit colonization of other commensal bacteria and/
or pathogens by occupying ecological niches, competing for resources,
producing metabolites and stimulating immune responses (Lawley
and Walker, 2013; Caballero and Pamer, 2015; Belkaid and Hand,
2014). In addition, bacterial-derived fatty-acid metabolites can impair
Candida albicans colonization of intestinal tissue, and a complex bacteri-
al microbiome inhibits translocation of pathogenic C. albicans across the
intestinal barrier (Kennedy and Volz, 1985). Consistent with resource
competition models, fungi often overgrow post-antibiotic treatment
and are associated with antibiotic-induced diarrhea (Sullivan et al.,2001; Krause et al., 2001; Mason et al., 2012). Conversely, introduction
of fungi or helminths can alter the composition of local, downstream,
and upstream bacterial microbiota (Kreisinger et al., 2015). Mecha-
nisms of microbiome remodeling are largely unknown, but in the con-
text of helminth infection it has been proposed that helminth-induced
alterations to nutrient access, antimicrobial peptide secretion, mucus
production and immune modulation may produce a ripple effect that
can alter multibiome composition at distant sites (Kreisinger et al.,
2015). Together, these data demonstrate that interactions between con-
stituents of the multibiome shape the overall structure of the intestinal
community (Fig. 4). The resulting disruptions in ecological homeostasis
may have far-reaching implications on host physiology, immune ho-
meostasis, and CID development, as discussed below.
3.2. Coevolution Between Intestinal Pathogens and the Multibiome: The
Bacterial Microbiome Cues ‘Home’
The gastrointestinal tract is colonizedwith commensal species along
its entire length. Although bacterial populations differ depending on
physical location (mouth, stomach, small and large intestine), a number
of pathogens have evolved to utilize conserved microbial features such
as bioﬁlm formation and microbe-associated molecular patterns
(MAMPs) to their advantage. Bacterial bioﬁlms provide a platform for
fungal colonization (Shirtliff et al., 2009; Iliev et al., 2012) and intestinal
helminths have evolved to use commensal bacteria as cues that they
have reached the appropriate destination to develop (Hayes et al.,
2010; Reynolds et al., 2014). Once established, some helminths support
expansion of immunoregulatory bacterial populations, which promote
Treg differentiation as an additional and indirectmeans of creating a tol-
erant immune environment that favors helminth persistence (Zaiss
et al., 2015).Moreover,multiple enteric viruses (huNoV, poliovirus, reo-
virus and mouse mammary tumor virus) have evolved to utilize bacte-
ria to improve infectivity and transmission by either stabilizing virion
structure, enhancing host receptor-binding, or inducing a tolerant envi-
ronment (Karst, 2016). Theseﬁndings indicate that intestinal pathogens
have evolved to utilize the bacterialmicrobiome to enhance their ﬁtness
and infectivity (Fig. 4).
4. Host-multibiome Interactions Inﬂuence Infection and Immunity
4.1. Nature vs. Nurture: Environmental Contributions to ImmuneHomeostasis
The crosstalk between environmental factors (including the intesti-
nal multibiome) and the mammalian immune system signiﬁcantly
shapes immune homeostasis, accounting for up to 75% of an individual's
cellular immune proﬁle, whereas genetic factors account for ~25–50%
(Orru et al., 2013; Brodin et al., 2015). Socio-economic status, diet, infec-
tion history, pet ownership, and exercise are all associated with inter-
individual differences in immune homeostasis and intestinalmultibiome
composition (Carr et al., 2016; Song et al., 2013). Intimate sharing of an
environment while co-habiting and co-parenting is linked to immune
proﬁle convergence between unrelated individuals (Carr et al., 2016).
Co-habitation is also coupled to bacterial microbiome convergence be-
tween unrelated individuals and even between their pets (Carr et al.,
2016; Song et al., 2013). Although these studies focused on the intestinal
bacterialmicrobiome, environmental factors likely inﬂuence othermem-
bers of the multibiome as well. Indeed, the intestinal virome is highly
similar between infant co-twins and as the twins are exposed to different
environmental conditions, similarity of the DNA virome diminishes by
adulthood (Reyes et al., 2010). Together, these ﬁndings indicate that
the intestinal multibiome is sensitive to environmental exposures and
contributes to immune homeostasis. This concept adds a layer of com-
plexity to the future of personalized medicine and suggests that the
human metagenome (an individual's genome plus the genomes of
their unique multibiome) may inﬂuence not only the development of
disease, but also responsiveness to therapeutic intervention.
Fig. 4. Interactions between multibiome members regulate the intestinal community. In addition to immune-mediated regulation, composition of the intestinal ecosystem is
dynamically regulated by interactions across taxonomic boundaries. A) A diverse commensal bacterial community limits outgrowth of opportunistic or pathogenic bacteria and
Candida albicans by niche competition for space and nutrients, production of metabolites and immune-mediated mechanisms. B) Bacteriophage diversity can dictate bacterial
community composition and drive evolution, through a predator-prey relationship. Some enteric pathogens have evolved to take advantage of the ubiquitous presence of intestinal
commensal bacteria. Bacteria expressing histo-blood group antigen (HBGA) promote human and murine Norovirus can promote infection of B cells. C) Helminths have evolved to
utilize cues from commensals, to ensure the life cycle is completed in the appropriate location and host. Helminth-induced type 2 responses promote a thickening of the mucus layer,
which can alter the colonizing microbiota species.
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The multibiome's inﬂuence on immune cells can affect the response
to infectious agents and vaccinations. Depletion of the murine bacterial
microbiome with antibiotics resulted in enhanced susceptibility to se-
vere systemic Lymphocytic Choriomeningitis Virus (LCMV) and Inﬂuen-
za A Virus lung infections (Abt et al., 2012; Ichinohe et al., 2011) that
was linked to commensal bacteria-dependent basal stimulation of anti-
viral signaling pathways in innate immune cells. Alternatively, enhanc-
ing innate immune signaling pathways with intestinal viral infection or
exposure to viral ligands was sufﬁcient to diminish colonization of
vancomycin-resistant Enterococcus faecium, an opportunistic bacteria
(Abt et al., 2016). These data indicate that innate immune cells integrate
signals from commensal bacteria or viruses to remain poised to respond
to pathogen infection across taxonomic boundaries.
Past infection history can also inﬂuence the outcome of future infec-
tions. Measles virus infection induces a long-term immunosuppressive
state and disables immune memory formation, increasing the risk of sec-
ondary bacterial or viral infection in children for 2–3 years after the initial
infection (Mina et al., 2015). Helminth-induced immunomodulation can
also impair antiviral immunity to newly acquired intestinal viral infection
(murine Norovirus, MNV) and enhance reactivation of latent herpesvirus
infection in a type 2 cytokine-dependent manner (Osborne et al., 2014;
Reese et al., 2014). It has been hypothesized that helminth-induced
alterations in the bacterial microbiome can indirectly inﬂuence immune
homeostasis and responses to pathogens. However, in the case of hel-
minth andMNVco-infection, the helminth-induced impairment of antivi-
ral immunitywas independent of alterations in the bacterial microbiome,
indicating that coevolution of helminths with the mammalian host has
enabled helminths to directly manipulate immune pathways (Osborne
et al., 2014).Many orally-administered vaccines (e.g. Rotarix, for Rotavirus and
theOral Polio Vaccine) developed and trialed in industrialized countries
are less effective in developing regions (Jiang et al., 2010; Naylor et al.,
2015). The impact of environmental exposures such as helminth infec-
tion, malnutrition and access to clean water all likely contribute to
diminished vaccine efﬁcacy. Emerging human data indicates that the
helminth-induced promotion of immunoregulatory CD4+ Treg cells
contribute to suppressed vaccine-induced immunity (Maizels, 2016),
and anti-helminthic therapies have been demonstrated to improve vac-
cine responses (Labeaud et al., 2009). Independent studies indicate that
unsanitary living conditions, bacterial dysbiosis and subclinical but in-
sidious environmental enteropathy (EE) are also associatedwith dimin-
ished efﬁcacy of orally administered vaccines (Naylor et al., 2015).
However,most studies do not test for helminth co-infections in children
with EE, thus the interplay between various environmental infections
and their impact on the immune response remains unknown. Recently,
it was demonstrated that multibiome co-infections in mice alter im-
mune homeostasis and impact vaccine responses (Reese et al., 2016).
A sequential co-infectionmodel could be useful to interrogate the inter-
play betweenmalnourishment and host-multibiome interactions in the
context of infection and immunity. This line of study could lead to new
understanding of how immune dysregulation can be overcome in these
settings to provide better protection from infectious disease.
5. Multibiome-host Interactions Inﬂuence Immune-mediated
Disease in the Gut and Beyond
Independent epidemiological studies have revealed a robust correla-
tion between bacterial microbiota dysbiosis and autoimmune and CIDs.
Given the comprehensive discussion of the importance of the bacterial
microbiome in these diseases (Belkaid and Hand, 2014), we will focus
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inﬂammation.5.1. Multibiome-host Interactions Inﬂuence Intestinal Inﬂammation and
Inﬂammatory Bowel Disease
Emerging data indicate that interactions between the virome, intes-
tinal bacteria andhost genetics can all contribute to IBD. Polymorphisms
in the autophagy gene Atg16L1 are associated with IBD (Cadwell et al.,
2010). Mice with a mutation in this gene infected with a persistent
strain of MNV and given dextran sodium sulfate (DSS - a chemical
that induces intestinal inﬂammation) developed enhanced colitis com-
pared to littermate controls. Notably, inﬂammation was dependent on
the presence of commensal bacteria, providing support for a multi-hit
model of IBD, in which viral infection, the bacterial microbiome and ge-
netic susceptibility collaborate in the development of IBD (Cadwell
et al., 2010). Similar reports of MNV-microbiome-host interactions in-
volved in IBD development have been observed in mice lacking a key
regulatory cytokine (IL-10) that mediates immune tolerance to the bac-
terial microbiota and resolves inﬂammation after infection (Basic et al.,
2014). Providing clinical relevance for these murine studies, epidemio-
logical data suggests that huNoV infections are associated with post-
infectious chronic irritable bowel syndrome and enteropathy develop-
ment (Zanini et al., 2012;Woodward et al., 2015) although the genetics
of susceptible populations remain unknown.
In other settings, the intestinal virome may mitigate the severity of
intestinal inﬂammation (Yang et al., 2016). IBD patients with polymor-
phisms in the genes encoding viral recognition proteins Toll-like recep-
tor (TLR) 3 and TLR7 have an elevated risk of hospitalization and TLR3/
7-deﬁcient mice develop exacerbated DSS-induced colitis compared to
wildtype animals, collectively suggesting that TLR3/7-mediated recog-
nition of the virome limits intestinal inﬂammation (Yang et al., 2016).
Further, depleting the murine virome with broad-spectrum (DNA and
RNA) antiviral treatment exacerbated DSS-induced colitis in wildtype
mice. Although the virome and bacterial microbiomewere both altered
by antiviral treatment, exogenous treatment with TLR3 and TLR7 ago-
nists reduced colitis severity independently of the microbiome, indicat-
ing that a virome-TLR3/7 signaling pathway may provide tonic anti-
inﬂammatory signals to the host directly (Yang et al., 2016). While
broad-spectrum antivirals are not commonly used, it is worth noting
that disrupting the commensal enteric virome could inﬂuence
multibiome composition and/or alter immune homeostasis.
Cross-talk between host genetics and the mycobiota also contrib-
utes to intestinal immune homeostasis. Polymorphisms in the fungal
pattern recognition receptor Dectin-1 have been detected in a subset
of IBD patients, and Dectin-1 deﬁcient mice developed severe DSS-
induced colitis that was associated with fungal dysbiosis (Iliev
et al., 2012). In the absence of this genetic susceptibility, long-term
antifungal treatment enhanced disease severity in two models of
IBD (Wheeler et al., 2016). Notably, bacterial dysbiosis is also associ-
ated with antifungal treatment, including decreased representation
of immunoregulatory Lactobacilli, whichmay alter the tolerant intes-
tinal immune environment (Wheeler et al., 2016). The recent identi-
ﬁcation of a fungal-bacterial bioﬁlm that is associated with IBD
(Hoarau et al., 2016) supports the hypothesis that fungi can inﬂuence
IBD progression through inter-multibiome as well as mycobiome-host
interactions.
Together, these studies suggest common themes in virome and
mycobiome interactions with the bacterial microbiome and host
genetics. In otherwise healthy individuals, both the virome and
mycobiome provide tonic signals that contribute to immune and
microbiome homeostasis. However, in the context of a genetic sus-
ceptibility that impairs recognition or response to these multibiome
members, the bacterial microbiome is implicated in intestinal
inﬂammation.5.2. Multibiome Inﬂuences on Systemic Chronic Inﬂammatory Diseases
Multiple sclerosis (MS) is a progressive autoimmune disease of the
central nervous system (Sospedra and Martin, 2016). Similar to other
CIDs, genetic susceptibility cannot fully explain the increased incidence
and prevalence of MS in industrialized regions and the impact of the
virome, bacterial microbiome and mycobiome on disease susceptibility
and progression are being investigated (Ascherio and Munger, 2016).
Epidemiologic data indicate an association between Epstein-Barr Virus
(EBV) infection history and development ofMS, especially if it manifest-
ed as severe infectious mononucleosis (Ascherio and Munger, 2016).
Supporting this correlation, using a pre-clinicalmousemodel ofMS (ex-
perimental autoimmune encephalomyelitis (EAE)), mice that harbored
latent murine gammaherpesvirus-68 (the murine homolog of EBV) in-
fection demonstrated more severe neuroinﬂammation and an immune
proﬁle that more closely resembled MS than the standard EAE model
(Casiraghi et al., 2012).
Emerging clinical data now suggest that the intestinal microbiome is
also disturbed in MS patients compared to healthy control populations,
although it remains unknown whether these alterations in bacterial
community populations are a cause or consequence of disease (Jangi
et al., 2016; Miyake et al., 2015). Notably, successful therapeutic inter-
vention is accompanied by restoration of a ‘normal’ bacterialmicrobiota
(Jangi et al., 2016). Pre-clinical animal models support the hypothesis
that the intestinal multibiome composition can impact neuronal immu-
nopathology. EAE symptoms do not develop in GF mice, but colonizing
GFmicewith the Th17 promoting bacteria Segmented Filamentous Bac-
teria (SFB) restores EAE susceptibility (Lee et al., 2011). Similarly, the
Th17 promoting fungus Candida albicans has been associatedwith exac-
erbated EAE and has been detected in the cerebrospinal ﬂuid of MS pa-
tients (Fraga-Silva et al., 2015). Conversely, probiotic mixtures of
regulatory T cell-promoting bacteria can dampen neuroinﬂammation
and EAE symptoms (Kwon et al., 2013). Collectively, theseﬁndings indi-
cate that themicrobiome can tune the immune response to impart pro-
tective or pathogenic effects during MS or EAE.
To our knowledge, studies speciﬁcally examining interactions be-
tween viruses, bacteria and the mycobiota in the context of MS have
not been reported. Although not discussed here, similar themes have
emerged in the context of other autoimmune diseases, including rheu-
matoid arthritis and Type 1 Diabetes, suggesting that multibiome inter-
actions with the host immune system could impact the onset,
progression or severity of numerous autoimmune diseases. Our under-
standing of how these ﬁndings relate to human disease is still in its in-
fancy, but microbial interventions may one day be incorporated into
treatment plans for multiple autoimmune disorders.6. Helminth Immunomodulation and Chronic InﬂammatoryDisease
The rising incidence and prevalence of autoimmune and CIDs in in-
dustrialized global regions is especially pronounced in comparison to
the low, yet stable prevalence of these diseases in lower income regions
(Maizels, 2016). The increased incidence of CIDs far exceeds the rate of
population evolution, implicating environmental changes associated
with industrialization as drivers of CIDs in the genetically predisposed.
The near abolishment of helminth infections in industrialized areas is
one recent, and potentially biologically important, environmental
change (Maizels, 2016). As an example, treatment of Gabonese children
with an anti-helminthic regimen resulted in a higher incidence of aller-
gic reactions compared to untreated controls (van den Biggelaar et al.,
2004). Parasitic infections have beenmajor drivers of human evolution;
populations from parasite-endemic regions have elevated frequencies
of polymorphisms in genes associated with immune function
(Fumagalli et al., 2011). These observations have lead to the hypothesis
that ancestral heritage from parasite-endemic regions imparts an ele-
vated risk of developing CIDswhen pairedwithWestern environmental
Fig. 5. The multibiome as a critical regulator of immune responses. Differences between industrialized and non-industrialized regions (infrastructure, sanitation, diet, medical
interventions, and multibiome exposures) are factors associated with the disparity in the prevalence of CIDs and the efﬁcacy of vaccines between different human populations. A) An
intestinal ecosystem with limited diversity is associated with antibiotic usage, decreased exposures to the multibiome and/or a ‘Westernized’ diet (high fat and sugar, low ﬁber). In
industrialized nations, this is associated with good vaccine efﬁcacy and decreased childhood mortality to infectious disease, but increased rates of autoimmune and CIDs. B) An
intestinal ecosystem rich in diversity may drive a balanced immune system. Non-industrialization is associated with endemic helminth infections, malnutrition, childhood morbidity
and mortality, and diminished vaccine efﬁcacy. Nevertheless, these regions have less autoimmune and CID incidence, indicating that factors that promote a complex multibiome might
support a balanced immune system. Further research could help determine how to establish optimalmultibiome diversity to limit CIDswithout compromising host-protective immunity.
52 H.A. Filyk, L.C. Osborne / EBioMedicine 13 (2016) 46–54exposures and the absence of helminth-mediated immune regulation
(Fig. 5).
The immunomodulatory effects of helminth colonization have been
proposed to limit intestinal inﬂammation and this is supported in both
murine and non-human primate models of IBD (Hang et al., 2010;
Broadhurst et al., 2012). As an example of bacteria-dependent helminth
immunomodulation, we highlight studies that examined intestinal in-
ﬂammation in genetically susceptible Nod2–/– mice (another risk allele
for human IBD development). A commensal bacterial species,
Bacteroides vulgatus, is responsible for the enhanced IBD severity
noted in Nod2–/– mice (Ramanan et al., 2014). Infection with the hel-
minthHeligmosomoides polygyrus prior to inducing intestinal inﬂamma-
tion was sufﬁcient to reduce B. vulgatus colonization and diminish IBD
severity in a type 2-dependent manner (Ramanan et al., 2016). Al-
though Nod2 polymorphisms and/or dysregulated B. vulgatus coloniza-
tion are not uniform features of IBD, these studies highlight the
importance of host-multibiome interactions in the development and
treatment of etiologically heterogeneous CIDs like IBD. However, de-
spite anecdotal successes, clinical trials of helminth immunotherapy
have been relatively unsuccessful (Maizels, 2016). These trials have pri-
marily used the eggs of a pig whipworm (Trichuris suis ova, TSO). Fur-
ther trials with other helminths, helminth-derived molecules or study
design that accounts for host-multibiome interactions may yield more
promising results.
Helminth immunotherapy is also being evaluated as a therapy for
MS, with varying success. So far, clinical trials with TSO in the context
of MS have demonstrated modest to no clinical improvement (Wolff
et al., 2012). However, in a prospective study where MS patients were
enrolled during remission, a subset of patients adventitiously acquired
a helminth infection and remained in remission while the helminth-
free cohort experienced periods of relapse and/or exacerbation
(Correale and Farez, 2007). Additionally, patients that received anti-
helminthic therapy relapsed and had reduced levels of circulating regu-
latory cytokines (Correale and Farez, 2007). This data supports thehypothesis that helminth-inspired therapies may aid MS patients, but
much remains unknown about the underlying immunologic and/or
multibiome-mediated mechanisms.
It is also important to recognize the inherent risks associated with
helminth infections. These organisms are a signiﬁcant cause of morbid-
ity andmortality in developing regions and can impair nutrient absorp-
tion, vaccine efﬁcacy and pathogen-speciﬁc immunity to viral, bacterial,
and malarial co-infections (McKay, 2015). Helminth-derived products
and type 2 cytokine therapy, instead of live-egg or worm infection, are
being actively investigated as a treatment for multiple CIDs, which
will hopefully provide similar beneﬁts while negating the risks of hel-
minth infections (Maizels, 2016; Ramanan et al., 2016).7. Outstanding Questions in Multibiome-host Research and
Translation
We are at the forefront of understanding the complex intestinal eco-
system and the impact of host-multibiome interactions on immune ho-
meostasis, health, and disease. Relatively novel kingdom agnostic
metagenomics may help account for the possible inﬂuences of all
multibiome constituents on a speciﬁc research question (Norman
et al., 2014). Increasingly available cell-type speciﬁc genetic and gnoto-
biotic animal models can be used to experimentally determine how di-
verse members of the multibiome inﬂuence each other and the host.
These approaches, along with standardized experimental conditions
and reporting (Stappenbeck and Virgin, 2016) will advance our under-
standing of multibiome-host interactions and the development of effec-
tive treatment strategies for multiple human diseases.
The American baseball manager Casey Stengel once said, “Finding
good players is easy. Getting them to play as a team is another story”.
In order to harness our expanding knowledge of how individual
multibiomemembers inﬂuence immune homeostasis and inﬂammato-
ry diseases, we must embrace the holistic nature of the intestinal
53H.A. Filyk, L.C. Osborne / EBioMedicine 13 (2016) 46–54ecosystem and aim to understand how these biodiverse entities interact
with each other and their host.
8. Search Strategy and Selection Criteria
Data for this reviewwere identiﬁed by searches of PubMed and refer-
ences from relevant articles using the search terms “microbiome”, “co-
infection”, “helminth immunotherapy”, “mycobiome” and “virome”.
Only articles published in English between 1954 and 2016were included;
however, preference was given to articles published between 2013 and
2016.
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